IL13RA2 and neoplasm: The IL-13Rα2 DNA vaccine, in combination with IL13-PE (a chimeric pseudomonas exotoxin), synergized to reduce murine breast tumor growth by multiple mechanisms, including direct tumor killing and increased T-cell tumor infiltration [107].